target audience: TECH BUYER  Publication date: Aug 2022 - Document type: Tech Buyer Presentation - Doc  Document number: # EUR249583722

European Life Sciences Policy and Regulatory Update, 2022

By:  Nino Giguashvili Loading


  • 16 slides

Get More

When you purchase this document, the purchase price can be applied to the cost of an annual subscription, giving you access to more research for your investment.

Related Links

On-line Presentation


This IDC Presentation summarizes the latest major European policy, regulatory, and development strategy news and initiatives shaping the technology landscape in the European life sciences market. As IDC Health Insights continues to provide in-depth research coverage of the European life sciences industry, this document aims to help life sciences organizations and their technology vendors stay aligned with the fast-evolving policy, funding, and regulatory developments in Europe to inform their digital initiatives and business strategies and capitalize on favorable opportunities.

"The latest policy and regulatory initiatives in the European life sciences industry have evolved around fostering secondary uses of health data, enabling a favorable environment for clinical trials, enhancing pharmacovigilance systems, and strengthening life sciences supply chain resilience for effective crisis preparedness and response."— Research Manager Nino Giguashvili, IDC Health Insights Europe


Do you have questions about this document
or available subscriptions?